2023 Q2 Form 10-K Financial Statement

#000149315223015544 Filed on May 05, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2022 Q4 2022
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit -$280.2K
YoY Change -92282.24%
Gross Profit Margin
Selling, General & Admin $131.2K $467.3K
YoY Change -51.83%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $820.00 $6.165K
YoY Change -48.69% -3.57%
% of Gross Profit
Operating Expenses $132.0K $473.4K
YoY Change 1.75% -51.51%
Operating Profit -$412.2K -$473.4K
YoY Change 217.75% -51.51%
Interest Expense $0.00 $1.499M
YoY Change
% of Operating Profit
Other Income/Expense, Net -$27.34K -$7.383M
YoY Change -110.23% 5648.51%
Pretax Income -$439.6K -$7.856M
YoY Change -419.72% 611.1%
Income Tax
% Of Pretax Income
Net Earnings -$439.6K -$7.856M
YoY Change -419.72% 611.1%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01 -$0.09
Diluted Earnings Per Share -$0.01 -$0.11
COMMON SHARES
Basic Shares Outstanding 71.76M shares 91.11M shares
Diluted Shares Outstanding 72.04M shares

Balance Sheet

Concept 2023 Q2 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.510K $0.00 $0.00
YoY Change
Cash & Equivalents $1.509K $0.00 $0.00
Short-Term Investments $0.00 $0.00
Other Short-Term Assets
YoY Change
Inventory $27.34K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $54.01K $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $2.358K $2.360K
YoY Change -72.34%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $270.3K $0.00
YoY Change -97.31%
Other Assets
YoY Change
Total Long-Term Assets $6.511M $2.358K $2.360K
YoY Change -35.12% -99.97%
TOTAL ASSETS
Total Short-Term Assets $54.01K $0.00
Total Long-Term Assets $6.511M $2.358K $2.360K
Total Assets $6.565M $2.358K $2.360K
YoY Change -34.58% -99.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $430.5K $31.50K $430.0K
YoY Change
Accrued Expenses $1.049M $6.770K $6.770K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $66.57K $50.69K $50.69K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.034M $1.377M $1.377M
YoY Change -0.22% -55.07%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $5.338M
YoY Change
Total Long-Term Liabilities $5.338M $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.034M $1.377M $1.377M
Total Long-Term Liabilities $5.338M $0.00 $0.00
Total Liabilities $8.372M $1.377M $1.377M
YoY Change 175.33% -55.07%
SHAREHOLDERS EQUITY
Retained Earnings -$24.05M -$23.53M
YoY Change 58.62% 50.13%
Common Stock $7.00 $7.00
YoY Change -22.22% -22.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.807M -$1.375M -$1.375M
YoY Change
Total Liabilities & Shareholders Equity $6.565M $2.358K $2.360K
YoY Change -34.58% -99.97%

Cashflow Statement

Concept 2023 Q2 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$439.6K -$7.856M
YoY Change -419.72% 611.1%
Depreciation, Depletion And Amortization $820.00 $6.165K
YoY Change -48.69% -3.57%
Cash From Operating Activities -$58.05K -$207.3K
YoY Change 290.15%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 59.56K $207.3K
YoY Change 290.15%
NET CHANGE
Cash From Operating Activities -58.05K -$207.3K
Cash From Investing Activities
Cash From Financing Activities 59.56K $207.3K
Net Change In Cash 1.510K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$58.05K -$207.3K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2021Q4 us-gaap Cash
Cash
usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2021 PNPL Gain Loss On Forgiveness Of Related Party Note Payable
GainLossOnForgivenessOfRelatedPartyNotePayable
usd
CY2021 PNPL Gain Loss On Impairment Of Equitymethod Investment
GainLossOnImpairmentOfEquitymethodInvestment
usd
CY2022 PNPL Increase Decrease In Contingent Liabilities
IncreaseDecreaseInContingentLiabilities
usd
CY2021 us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2021 PNPL Proceeds From Stock Subscription Received
ProceedsFromStockSubscriptionReceived
usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001654672
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022Q4 us-gaap Cash
Cash
usd
CY2022Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
usd
CY2022Q4 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2021Q4 PNPL Subscription Received Shares To Be Issued
SubscriptionReceivedSharesToBeIssued
usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2022 PNPL Professional Fees Related Parties
ProfessionalFeesRelatedParties
usd
CY2021 PNPL Gain Loss On Forgiveness Of Related Party Note Payable
GainLossOnForgivenessOfRelatedPartyNotePayable
usd
CY2021 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
usd
CY2022 PNPL Gain On Settlement Of Debt
GainOnSettlementOfDebt
usd
CY2022 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
usd
CY2021 PNPL Gain Loss On Impairment Of Equitymethod Investment
GainLossOnImpairmentOfEquitymethodInvestment
usd
CY2021 PNPL Gain On Forgiveness Of Debt To Related Party
GainOnForgivenessOfDebtToRelatedParty
usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
usd
CY2022 PNPL Stock Issued During Period Value Cancellation Of Common Stock Pursuant To Equity Investment Sale Agreement
StockIssuedDuringPeriodValueCancellationOfCommonStockPursuantToEquityInvestmentSaleAgreement
usd
CY2021 PNPL Gain Loss On Debt Forgiveness
GainLossOnDebtForgiveness
usd
CY2022 PNPL Gain On Debt Settlement
GainOnDebtSettlement
usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2021 PNPL Liabilities Settled By Affiliate
LiabilitiesSettledByAffiliate
usd
CY2021 PNPL Gain On Forgiveness Of Related Party Note Payable
GainOnForgivenessOfRelatedPartyNotePayable
usd
CY2021 PNPL Non Cash Gain On Sale Of Subsidiary
NonCashGainOnSaleOfSubsidiary
usd
CY2021 PNPL Termination Of Stock Purchase Agreement
TerminationOfStockPurchaseAgreement
usd
CY2021 PNPL Cancellation Of Common Stock Pursuant To Equity Investment Sale Agreement
CancellationOfCommonStockPursuantToEquityInvestmentSaleAgreement
usd
CY2022 PNPL Deposit On Stock Purchase Agreement
DepositOnStockPurchaseAgreement
usd
CY2022 us-gaap Stock Issued1
StockIssued1
usd
CY2022 PNPL Related Party Debt Issued For Relief Of Accounts Payable
RelatedPartyDebtIssuedForReliefOfAccountsPayable
usd
CY2022 PNPL Common Stock Issued As Settlement Of Related Party Debt
CommonStockIssuedAsSettlementOfRelatedPartyDebt
usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
000-55896
CY2022 dei Entity Registrant Name
EntityRegistrantName
PINEAPPLE, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-5185484
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
10351 Santa Monica Blvd.
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 420
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Los Angeles
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90025
CY2022 dei City Area Code
CityAreaCode
877
CY2022 dei Local Phone Number
LocalPhoneNumber
310-7675
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
298211 usd
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
71763569 shares
CY2022 dei Auditor Firm
AuditorFirmId
5041
CY2022 dei Auditor Name
AuditorName
BF Borgers CPA PC
CY2022 dei Auditor Location
AuditorLocation
Lakewood, CO
CY2021Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
100000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
100000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2358 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8524 usd
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
9288298 usd
CY2022Q4 us-gaap Assets
Assets
2358 usd
CY2021Q4 us-gaap Assets
Assets
9396822 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
398489 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
715546 usd
CY2022Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
31500 usd
CY2021Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
16500 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
6771 usd
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
6771 usd
CY2022Q4 PNPL Settlement Payable Related Party Current
SettlementPayableRelatedPartyCurrent
615000 usd
CY2021Q4 PNPL Settlement Payable Related Party Current
SettlementPayableRelatedPartyCurrent
615000 usd
CY2021Q4 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
529948 usd
CY2022Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
30851 usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
886918 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
19838 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
19838 usd
CY2022Q4 PNPL Advance On Agreements Current
AdvanceOnAgreementsCurrent
169000 usd
CY2021Q4 PNPL Advance On Agreements Current
AdvanceOnAgreementsCurrent
169000 usd
CY2022Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
105523 usd
CY2021Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
105523 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1376972 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3065044 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1376972 usd
CY2021Q4 us-gaap Liabilities
Liabilities
3065044 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0000001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0000001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0000001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0000001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71163569 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71163569 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
91163569 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
91163569 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
7 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
9 usd
CY2022Q4 PNPL Subscription Received Shares To Be Issued
SubscriptionReceivedSharesToBeIssued
150000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
22004079 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
22004077 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-23528700 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15672308 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1374614 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
6331778 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2358 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9396822 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23421 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20587 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
210828 usd
CY2021 us-gaap Professional Fees
ProfessionalFees
392406 usd
CY2021 PNPL Professional Fees Related Parties
ProfessionalFeesRelatedParties
340000 usd
CY2022 PNPL Management Consulting Fees Related Parties
ManagementConsultingFeesRelatedParties
233000 usd
CY2021 PNPL Management Consulting Fees Related Parties
ManagementConsultingFeesRelatedParties
217000 usd
CY2022 us-gaap Depreciation
Depreciation
6165 usd
CY2021 us-gaap Depreciation
Depreciation
6393 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
473414 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
976386 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-473414 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-976386 usd
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1499355 usd
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-200318 usd
CY2022 PNPL Gain Loss On Forgiveness Of Related Party Note Payable
GainLossOnForgivenessOfRelatedPartyNotePayable
30000 usd
CY2022 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
386287 usd
CY2021 PNPL Gain On Settlement Of Debt
GainOnSettlementOfDebt
77360 usd
CY2021 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
5475 usd
CY2022 PNPL Gain Loss On Impairment Of Equitymethod Investment
GainLossOnImpairmentOfEquitymethodInvestment
-10787652 usd
CY2022 PNPL Gain On Forgiveness Of Debt To Related Party
GainOnForgivenessOfDebtToRelatedParty
12000 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1477032 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7382978 usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-128433 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7856392 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1104819 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-7856392 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1104819 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91108774 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89138014 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
6729597 usd
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
340000 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
284000 usd
CY2021 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
33000 usd
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
50000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1104819 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
6331778 usd
CY2022 PNPL Stock Issued During Period Value Common Stock Subscription Received
StockIssuedDuringPeriodValueCommonStockSubscriptionReceived
150000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-7856392 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1374614 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-7856392 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1104819 usd
CY2022 us-gaap Depreciation
Depreciation
6165 usd
CY2021 us-gaap Depreciation
Depreciation
6393 usd
CY2022 PNPL Gain Loss On Debt Forgiveness
GainLossOnDebtForgiveness
12000 usd
CY2021 PNPL Gain On Debt Settlement
GainOnDebtSettlement
77360 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1477032 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
340000 usd
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1499355 usd
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-200318 usd
CY2022 PNPL Gain Loss On Forgiveness Of Related Party Note Payable
GainLossOnForgivenessOfRelatedPartyNotePayable
30000 usd
CY2022 PNPL Gain Loss On Impairment Of Equitymethod Investment
GainLossOnImpairmentOfEquitymethodInvestment
-10787652 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-255053 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
120977 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
15000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
16500 usd
CY2021 PNPL Increase Decrease In Contingent Liabilities
IncreaseDecreaseInContingentLiabilities
5475 usd
CY2022 us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
-5282 usd
CY2022 us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
108468 usd
CY2021 us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
439391 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-207265 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-53125 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
284000 usd
CY2022 PNPL Proceeds From Stock Subscription Received
ProceedsFromStockSubscriptionReceived
150000 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
119285 usd
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
58075 usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
62020 usd
CY2021 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
288950 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
207265 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
53125 usd
CY2022 PNPL Liabilities Settled By Affiliate
LiabilitiesSettledByAffiliate
156775 usd
CY2022 PNPL Gain On Forgiveness Of Related Party Note Payable
GainOnForgivenessOfRelatedPartyNotePayable
30000 usd
CY2022 PNPL Non Cash Gain On Sale Of Subsidiary
NonCashGainOnSaleOfSubsidiary
386287 usd
CY2022 PNPL Termination Of Stock Purchase Agreement
TerminationOfStockPurchaseAgreement
100000 usd
CY2022 PNPL Cancellation Of Common Stock Pursuant To Equity Investment Sale Agreement
CancellationOfCommonStockPursuantToEquityInvestmentSaleAgreement
2 usd
CY2021 PNPL Deposit On Stock Purchase Agreement
DepositOnStockPurchaseAgreement
100000 usd
CY2021 us-gaap Stock Issued1
StockIssued1
33000 usd
CY2021 PNPL Related Party Debt Issued For Relief Of Accounts Payable
RelatedPartyDebtIssuedForReliefOfAccountsPayable
218734 usd
CY2021 PNPL Common Stock Issued As Settlement Of Related Party Debt
CommonStockIssuedAsSettlementOfRelatedPartyDebt
50000 usd
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
1983-08-03
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0000001
CY2022 PNPL Gain Loss On Impairment Of Equitymethod Investment
GainLossOnImpairmentOfEquitymethodInvestment
-10787652 usd
CY2022Q3 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
10000 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
376287 usd
CY2022Q3 us-gaap Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
10000 usd
CY2022 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
386287 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_845_eus-gaap--UseOfEstimates_zJXyxhNQ9dOf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i><span id="xdx_860_z7cOV1uLh8Fj">Use of Estimates in Financial Reporting</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the recoverability and useful lives of long-lived assets, assessment of legal accruals, the fair value of the Company’s stock, stock-based compensation and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-207265 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-23528700 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-7856392 usd
CY2022 PNPL Proceed From Issuance Of Common Stock
ProceedFromIssuanceOfCommonStock
150000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
55473 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
55473 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
53115 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
46949 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2358 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8524 usd
CY2022 us-gaap Depreciation
Depreciation
6165 usd
CY2021 us-gaap Depreciation
Depreciation
6393 usd
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
11000000 usd
CY2022Q4 PNPL Investment Owned Subject To Option Exercise Price
InvestmentOwnedSubjectToOptionExercisePrice
0.55
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1499355 usd
PNPL Gain Loss On Impairment Of Equitymethod Investment
GainLossOnImpairmentOfEquitymethodInvestment
-10787652 usd
CY2022 us-gaap Stock Issued During Period Shares Purchase Of Assets
StockIssuedDuringPeriodSharesPurchaseOfAssets
20000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0000001
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1477032 usd
CY2022Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
30851 usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
886918 usd
CY2021 PNPL Stock Issued During Period Common Stock Pursuant
StockIssuedDuringPeriodCommonStockPursuant
1829631 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71163569 shares
CY2022Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
615000 usd
CY2021Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
615000 usd
CY2022Q4 PNPL Advances On Agreements Current
AdvancesOnAgreementsCurrent
169000 usd
CY2021Q4 PNPL Advances On Agreements Current
AdvancesOnAgreementsCurrent
169000 usd
CY2022 us-gaap Payments For Rent
PaymentsForRent
3750 usd
CY2022Q4 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
525000000 shares
CY2022Q4 PNPL Capital Stock Par Value
CapitalStockParValue
0.0000001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71163569 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71163569 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71163569 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71163569 shares
CY2021 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
2630000 shares
CY2021 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
284000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
800552 usd
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71163569 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
91163569 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
91163569 shares
CY2022Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
150000 usd
CY2022Q1 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
400000 usd
CY2022Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.25
CY2022Q2 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
100000 usd
CY2022Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.50
CY2022Q4 us-gaap Preferred Stock Shares Subscribed But Unissued Value
PreferredStockSharesSubscribedButUnissuedValue
150000 usd
CY2022 PNPL Deferred Tax Valuation Allowances Percentage
DeferredTaxValuationAllowancesPercentage
1 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.07 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.07 pure
CY2022 PNPL Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate Related Party Interest
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRateRelatedPartyInterest
0 pure
CY2021 PNPL Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate Related Party Interest
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRateRelatedPartyInterest
0 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.28 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.28 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
2001247 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
1868691 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
800552 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
1494837 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
1494837 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
17867 usd
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
17867 usd
CY2022Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
2185 usd
CY2021Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
2185 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
4316688 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
4184132 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4316688 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4184132 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
7500000 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
6300000 usd
CY2022 PNPL Operating Loss Carryforward Expiration
OperatingLossCarryforwardExpiration
expire beginning in 2036
CY2022Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2500000 shares

Files In Submission

Name View Source Status
0001493152-23-015544-index-headers.html Edgar Link pending
0001493152-23-015544-index.html Edgar Link pending
0001493152-23-015544.txt Edgar Link pending
0001493152-23-015544-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
MetaLinks.json Edgar Link pending
pnpl-20221231.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
pnpl-20221231_cal.xml Edgar Link unprocessable
pnpl-20221231_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
pnpl-20221231_pre.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
pnpl-20221231_def.xml Edgar Link unprocessable